Anjalie Bartee was a normal, healthy junior in high school in Omaha, NE when she began experiencing headaches and vision changes. The condition persisted and worsened, and an ophthalmologist detected pressure on the brain and sent them to the ER at their local children's hospital.
The diagnosis was a brain tumor, diffuse midline glioma (DMG); she was given a few months to a year, maybe two if lucky, to live. After the standard 6 weeks of radiation, the tumor's growth was not deterred; her condition was not temporarily improving as hoped.
Her physicians were aware of the clinical trial with ONC201, and had Anjalie begin within a month's time; she continues to participate, now 19 months later, and is doing well.
Anjalie and her parents join us to share the details of their journey together, and hopeful plans for the future.